Navigation Links
Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
Date:6/26/2009

ard their important efforts in oncology research.

About JAVLOR(R) (vinflunine):

Discovered by scientists at the Pierre Fabre Research Center, vinflunine is a new bi-fluorinated MTI (Microtubule inhibitor) obtained by chemistry exploiting the reactivity of Vinca scaffold in superacidic media. Such strategy, finalized in collaboration with experts at the University of Poitiers (France), enabled the selective introduction of two fluorine atoms in a part of that structure previously inaccessible by classic chemistry, thereby leading to the first bi-fluorinated vinca alkaloid.

Besides its original structure, JAVLOR(R) exhibits unique pharmacological properties and is also devoid of any unpredictable major toxicity and does not induce cumulative toxicity.

Its every 3 weeks administration enables convenient hospital treatment on an out patient basis (a 20 minutes infusion without any IV premedication).

JAVLOR(R) 25 mg/ml solution for infusion has been approved as monotherapy for the treatment of adult patients with advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum-containing regimen.

About Laboratoires Pierre Fabre

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research sector, are employed.

Its therapeutical areas are ethical products, healthcare products and dermocosmetics with the brands Avene, Ducray, A Derma, Galenic, Klorane and Rene Furterer. In 2008, Pierre Fabre Medicament dedicated 33% of its annual turnover to R&D in five main therapeutic directions: oncology, the Central Nervous System, cardiology, internal medicine /urology and dermatology.

To learn more about Pierre Fabre, please refer to

SOURCE Pierre Fabre SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... ... With TransCel from Pixel Film Studios users can simulate celluloid media transitions ... users have full control over camera position and angle within 3D space from start ... text, and more. With TransCel the possibilities are endless. , Users have full control ...
(Date:9/4/2015)... ... September 04, 2015 , ... The Providence Fertility Center will ... about their fertility and egg freezing. , Date and Time: October 8, 2015 at ... , This hip and informative event will discuss the basics of female fertility and ...
(Date:9/4/2015)... , ... September 04, 2015 , ... After wearing the ... desperate need of new apparel. In an effort to assist the team, the Jones ... launched a charity drive to raise funds for the new uniforms. , As is ...
(Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts (SE) ... Year” awards at this year’s Microsoft Worldwide Partner Conference that was held in ... Year” Award Winner for Data Platform services, the 2015 HP and Microsoft “Outstanding ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily stressors and distractions ... and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons ... the island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 2Health News:The Jones Agency Serves Up a Charity Drive to Fund New Uniforms for the Sprayberry High School Girls Volleyball Team 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3
... receive a combination of medication and a psychosocial intervention ... have improved insight, quality of life and social functioningthan ... the September issue of Archives of General Psychiatry ... are the mainstay of therapy for patients with schizophrenia, ...
... one-fifth of fathers in the United Kingdom appear to experience ... year of age, with the highest rates in the first ... that will appear in the November print issue of ... JAMA/Archives journals. "Depression in parents is associated with adverse ...
... (Sept. 3) A long-term study of women with a ... who elected major preventive surgeries had a significantly reduced risk ... the Journal of the American Medical Association, confirms the view ... director of the Greehey Children,s Cancer Research Institute at The ...
... Mass. - Phosphorus, a mineral element found in rocks ... detergents and other industrial and household chemicals. Once phosphorus ... is hazardous and expensive, and chemists have been trying ... professor Christopher Cummins and one of his graduate students, ...
... progression of the giant iceberg that calved from Greenland,s Petermann ... iceberg, the largest in the northern hemisphere, is now entering ... Lincoln Sea and Arctic Ocean with Baffin Bay. The ... of the country,s glaciers and until August it had ...
... Researchers at Queen,s University have found that people with ... without the disease, but have significant difficulty switching from ... towards understanding the aspects of the illness that affect ... "We often think of Parkinson,s disease as being a ...
Cached Medicine News:Health News:Combining medication and psychosocial treatments may benefit patients with early-stage schizophrenia 2Health News:Parents at highest risk for depression in the first year after child's birth 2Health News:For some women, preventive mastectomies pay off 2Health News:MIT moves toward greener chemistry 2Health News:MIT moves toward greener chemistry 3Health News:Earth from space: Giant iceberg enters Nares Strait 2
(Date:9/4/2015)... Sept. 4, 2015  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the Wells Fargo Securities 2015 Healthcare Conference in ... September 10 th at 2:30 p.m. Eastern Time. To ... discussion, please visit the Investors section of the Company,s Web ... for 14 days after the event.  Orexigen Contact: ...
(Date:9/4/2015)... , Sept. 4, 2015  Allergan plc (NYSE: ... Brent Saunders , CEO and President of Allergan, will ... the Morgan Stanley Global Healthcare Conference 2015 in ... http://photos.prnewswire.com/prnh/20150612/222796LOGO The presentation will take place ... at the Grand Hyatt New York, 109 East 42nd Street, ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ) has announced ... Ibandronate Market, 2010-2019" report to their offering. ... name of Bondronat in Germany and ... approved by the FDA to come into the market as ... Boniva. However, since drug makers later developed more convenient dose, ...
Breaking Medicine Technology:Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3Investigation Report on China's Sodium Ibandronate Market 2010-2019 2
... OTI's new Spectral system is a combination ... Laser Ophthalmoscope (SLO) system that provides suberb, ... choroidal-retina structure. With the advancements of spectral ... of up to 27,000 A-Scans per second ...
... SC is an ideal gamma ... with the ability to perform ... views, Myocardial perfusion diagnosis and ... low cost and space efficient ...
... Coil is intended for: embolization of those ... their location, or the patient's general medical ... team to be a) very high risk ... b) inoperable.,The GDC is also intended for ...
Designed to have a shock-absorbing force, providing less bounce or wasted force....
Medicine Products: